一项关于药品废弃物返回芬兰药房的数量,类型,经济价值和原因的研究
Mella Louhisalmi1, Piia Lavikainen1, Charlotta Sandler2
1School of Pharmacy, University of Eastern Finland, Yliopistonrinne 3, 70210 Kuopio, Finland.
概括
芬兰的家庭制药废物很大,退回的药物每年为社会造成数百万美元的损失. 退货的主要原因包括开封后的保质期短和大包装尺寸,突出了减少废物战略的必要性.
科学领域:
- 制药废弃物管理 制药废弃物管理
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 大量未使用的药物有助于制药废物.
- 芬兰正在积极寻找减少制药浪费的方法.
- 芬兰关于家庭制药废物的数据有限.
研究的目的:
- 量化和定格家庭制药废物返回到芬兰社区药房.
- 为了确定这些返回的制药废物的经济价值.
- 确定家庭制药废弃物退货的主要原因.
主要方法:
- 芬兰82家社区药房在2022年5月3天内进行的一项调查.
- 出于客户原因,通过电子表格收集药房回报和纸质问卷的数据.
- 经济估值使用芬兰药品价格和加权平均值;对频率和百分比的统计分析.
主要成果:
- 5173种药物被返回;66%是处方药.
- 神经系统 (18%),呼吸系统 (16%),食道/新陈代谢 (12%) 是最常见的药物组.
- 返回药物的估计年经济价值为8100万欧元,社会成本为4300万欧元.
结论:
- 返回药店的大量药品废物需要付出相当大的成本.
- 药品在开封后的保质期有限 (36%) 和大包装 (22%) 是造成浪费的主要原因.
- 减少家庭制药浪费需要在整个制药供应链中采取协作行动.
相关概念视频
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Drug Excretion: Miscellaneous Routes
67
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
67
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K
One-Compartment Open Model: Urinary Excretion Data and Determination of k
175
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
175
Analysis of Population Pharmacokinetic Data
256
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
256


